BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)

NCT01453595 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
10
Enrollment
OTHER
Sponsor class

Stopped Given the number of toxicities seen and the difficulty with patient retention in the dose escalation portion, the sponsor decided to close the trial.

Conditions

Interventions

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators